Clinical Trial

Western Sydney Kidney Injury Biopsy Study

Study acronym: WESTKiD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigators aim to develop a clinically validated, histological acute tubular injury (ATI) scoring system to help improve diagnostic precision and predict clinical outcomes following ATI. To use an unbiased, data-driven approach, correlating pathological features (including digital pathology), key signatures using spatial technologies (transcriptomics or proteinomics) with relevant clinical outcomes. Spatial technologies (including spatial transcriptomics and spatial proteinomics) allow the use of 'precision pathology' to study the critical link between molecular characteristics to histological structure.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-03; most recent amendment 2024-04-22.
Trial Details
NCT Number NCT06254677
Lead Sponsor Western Sydney Local Health District
Conditions Kidney Injury
Enrollment 1,000 participants
Start Date 2024-05-01
Primary Completion 2035-01-01 (estimated)
Study Completion 2040-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-24